Jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO) the BIO Asia–Taiwan International Conference and Exhibition was held for the first time in 2019. An endorsement of Taiwan's standing as a leading Asian biomedical industry hub, the gathering was a resounding success. With the onset of the COVID-19 pandemic, the 2020 edition was successfully transformed into a unique blend of online and live gatherings — BIO Asia–Taiwan 2020 Online + Live. In the following year BIO Asia–Taiwan 2021 Online was held, with an additional onsite exhibition taking place later in the year. With these new event formats, the regional and international biotechnology community was able to successfully step out from the shadow of the global pandemic and develop all-new regional and global bio-business opportunities.
This year BIO Asia–Taiwan 2022 Onsite + Onlinewill continue in a mixed online + live format, this year to be held July 27-31, with early access starting July 25. The event aims to build on the success of recent years’ gatherings to again bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia, and explore business opportunities with Taiwan’s emerging biotech sector. The five-day gathering will feature internationally renowned speakers, online company presentations from Asia and around the world, BIO One-on-One Partnering™ meetings, online seminars and workshops, and an online exhibition. Online meeting lounges and other social media-type activities will facilitate and replicate the social and networking elements so important to the typical conference experience.
This year's theme, Connecting the Asian Value Chain, reflects the scope and importance of linkage with Asian bioindustry entities in order to maximize opportunity, innovation and ROI. Featuring the latest advances from the therapeutic, diagnostic, medical equipment, and service sectors, BIO Asia–Taiwan 2022 Onsite + Online is notably hosted in Taiwan, recognized worldwide not only for its efforts to date in successfully fighting the spread of the pandemic, but also in cultivating a high level of innovation and international engagement within the biomedical sector. The event promises attendees a wide range of seminars and panel discussions on industry-critical, cutting-edge topics from 100+ renowned speakers, while providing networking with fully-vetted featured companies and solution providers.
The conference will focus on three major topic areas: Innovation – covering precision health, AI and digital health, and others. Market & Supply – including biosimilars, vaccines, contract development & manufacturing, APIs and generics, among others. Investment – covering early-stage financing, cross border investment, capital markets, and more.
BIO Asia–Taiwan 2022 Onsite + Online will again feature the renowned BIO One-on-One Partnering™ platform, an easy-to-use online meeting scheduling system to search for and identify potential partners, collaborators, investors and in- and out-licensing opportunities. Face-to-face meetings will be held over private and secure video links 24 hours a day during the event period. With over 6,000 meetings made via the system during BIO Asia–Taiwan 2021, we expect to exceed that number during the 2022 event. Registration will open in May and the BIO One-on-One Partnering system will open in June.
For more information visit www.bioasiataiwan.com.
BIO Asia–Taiwan 2022 Onsite + Online will showcase Taiwan's growing digital advantage in the biomed sector and spotlight biotech, pharmaceutical, medical devices, precision medicine advances, as well as AI applications, ICT and IoT technologies, and new healthcare/medical investment opportunities.
From any point on the globe, make sure to join us at BIO Asia–Taiwan 2022 Onsite + Online, and let's show that while we may not be able to gather in person, nothing stops innovation!